CAS Medical Systems, Inc. Announces Addition to Executive Team
Nathan B. Harris Joins as Vice President of Sales and Marketing
FOR IMMEDIATE RELEASE:
Mr. Harris was most recently Vice President of US Sales and Global Marketing at Salient Surgical Technologies (formerly TissueLink), an advanced medical technology company that develops and markets RF based surgical products. Prior to TissueLink he served as National Sales Director of the Electrophysiology Division and Business Director of the Pacing Division of Medtronic, Inc. Mr. Harris has also held various marketing and sales positions with Medtronic, Inc., Cardiac Pacemakers, Inc. (Guidant), and Honeywell, Inc. He is a graduate of the College of New Jersey with a degree in Electronic Engineering Technology, the Executive Program at Darden University, and is a candidate for a M.B.A. at St. Thomas University.
Andrew E. Kersey, President and CEO of CASMED, said, “Nathan brings valuable experience in setting strategic direction for diverse products and market segments to achieve long-term market share and meet financial targets. His knowledge of the hospital marketplace will be utilized to target CASMED’s best strategic opportunities. Further, Nathan’s extensive experience in designing sales and marketing plans and developing distribution networks, will enable CASMED to accelerate growth and meet our objectives.”
About CASMED® - Monitoring What’s Vital
The Company’s product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Absolute Cerebral Oximeter; the low-acuity monitoring of its full line of vital signs monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
For further information regarding CAS Medical Systems, Inc., visit the Company’s website at www.casmed.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company’s Form 10-K for the year ended December 31, 2007 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
# # #